Position in BNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,417,827
+$183,318 QoQ
Shares Held
47,478
-0.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 282 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. BNTX ranks #56 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in BNTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,417,827 | 47,478 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,234,509 | 47,643 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,591,210 | 48,227 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,736,422 | 48,027 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,115,709 | 66,833 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,742,264 | 74,042 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,437,085 | 74,042 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,973,548 | 75,554 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,985,212 | 86,924 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $8,018,739 | 86,924 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,173,958 | 86,924 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,490,355 | 87,356 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,382,894 | 86,935 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,141,358 | 121,549 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $11,370,602 | 75,693 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,304,560 | 39,328 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,067,909 | 33,990 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,797,334 | 33,990 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $7,570,554 | 29,366 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $6,997,552 | 25,633 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||